Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates

Pediatric Research (2023)Cite this article

Abstract

Background

Despite a growing understanding of bronchopulmonary dysplasia (BPD) and advances in management, BPD rates remain stable. There is mounting evidence that BPD may be due to a systemic insult, such as acute kidney injury (AKI). Our hypothesis was that severe AKI would be associated with BPD.

Methods

We conducted a secondary analysis of premature infants [24–27 weeks gestation] in the Recombinant Erythropoietin for Protection of Infant Renal Disease cohort (N = 885). We evaluated the composite outcome of Grade 2/3 BPD or death using generalized estimating equations. In an exploratory analysis, urinary biomarkers of angiogenesis (ANG1, ANG2, EPO, PIGF, TIE2, FGF, and VEGFA/D) were analyzed.

Results

594 (67.1%) of infants had the primary composite outcome of Grade 2/3 BPD or death. Infants with AKI (aOR: 1.69, 95% CI: 1.16–2.46) and severe AKI (aOR: 2.05, 95% CI: 1.19–3.54). had increased risk of the composite outcome after multivariable adjustment Among 106 infants with urinary biomarkers assessed, three biomarkers (VEGFA, VEGFD, and TIE2) had AUC > 0.60 to predict BPD.

Conclusions

Infants with AKI had a higher likelihood of developing BPD/death, with the strongest relationship seen in those with more severe AKI. Three urinary biomarkers of angiogenesis may have potential to predict BPD development.

Impact

  • AKI is associated with lung disease in extremely premature infants, and urinary biomarkers may predict this relationship.

  • Infants with AKI and severe AKI have higher odds of BPD or death. Three urinary angiogenesis biomarkers are altered in infants that develop BPD.

  • These findings have the potential to drive future work to better understand the mechanistic pathways of BPD, setting the framework for future interventions to decrease BPD rates.

  • A better understanding of the mechanisms of BPD development and the role of AKI would have clinical care, cost, and quality of life implications given the long-term effects of BPD.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Consort diagram of infants in the study.
Fig. 2: Urinary biomarkers in infants.

Data availability

De‐identified individual participant data are available through the NINDS Data Archive: https://www.ninds.nih.gov/Current‐Research/Research‐ Funded‐NINDS/Clinical‐Research/Archived‐Clinical‐ Research‐Datasets. The data will be de‐identified and a limited access data is available through a request form on that page. Data dictionaries, in addition to study protocol, the statistical analysis plan, and the informed consent form are included. The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.

References

  1. Baraldi, E., Carraro, S. & Filippone, M. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum. Dev. 85, S1–S3 (2009).

    Article  PubMed  Google Scholar 

  2. Jensen, E. A. et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. an evidence-based approach. Am. J. Respir. Crit. Care Med. 200, 751–759 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bancalari, E. H. & Jobe, A. H. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J. Pediatr. 161, 585–588 (2012).

    Article  PubMed  Google Scholar 

  4. Thébaud, B. & Abman, S. H. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am. J. Respir. Crit. Care Med. 175, 978–985 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Askenazi, D. J. et al. Prevalence of acute kidney injury (Aki) in extremely low gestational age neonates (Elgan). Pediatr. Nephrol. 35, 1737–1748 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Basu, R. K. & Wheeler, D. S. Kidney-lung cross-talk and acute kidney injury. Pediatr. Nephrol. 28, 2239–2248 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Starr, M. C. et al. Acute kidney injury and bronchopulmonary dysplasia in premature neonates born less than 32 weeks’ gestation. Am. J. Perinatol. 37, 341–348 (2020).

    Article  PubMed  Google Scholar 

  8. Askenazi, D. et al. Acute kidney injury is associated with bronchopulmonary dysplasia/mortality in premature infants. Pediatr. Nephrol. 30, 1511–1518 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Levesque, B. M. et al. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology 104, 56–64 (2013).

    Article  CAS  PubMed  Google Scholar 

  10. Kang, D. H., Hughes, J., Mazzali, M., Schreiner, G. F. & Johnson, R. J. Impaired angiogenesis in the remnant kidney model: Ii. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12, 1448–1457 (2001).

    Article  CAS  PubMed  Google Scholar 

  11. Mansour, S. G. et al. The association of angiogenesis markers with acute kidney injury and mortality after cardiac surgery. Am. J. Kidney Dis. 74, 36–46 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bose, C. et al. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr. Res. 69, 347–353 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat. Rev. Mol. Cell Biol. 10, 165–177 (2009).

    Article  CAS  PubMed  Google Scholar 

  14. Ahlfeld, S. K., Gao, Y., Conway, S. J. & Tepper, R. S. Relationship of structural to functional impairment during alveolar-capillary membrane development. Am. J. Pathol. 185, 913–919 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Juul, S. E. et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N. Engl. J. Med. 382, 233–243 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zappitelli, M. et al. Developing a neonatal acute kidney injury research definition: a report from the niddk neonatal aki workshop. Pediatr. Res. 82, 569–573 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Starr, M. C. et al. Impact of processing methods on urinary biomarkers analysis in neonates. Pediatr. Nephrol. 33, 181–186 (2018).

    Article  PubMed  Google Scholar 

  18. Askenazi, D. J. et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr. Res. 70, 302–306 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lassus, P. et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am. J. Respir. Crit. Care Med. 164, 1981–1987 (2001).

    Article  CAS  PubMed  Google Scholar 

  20. Askenazi, D. J. et al. Acute kidney injury urine biomarkers in very low-birth-weight infants. Clin. J. Am. Soc. Nephrol. 11, 1527–1535 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Liu, K. D. et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit. Care 13, R104 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gist, K. M. et al. Assessment of the independent and synergistic effects of fluid overload and acute kidney injury on outcomes of critically Ill children. Pediatr. Crit. Care Med. 21, 170–177 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Baker, C. D. & Abman, S. H. Impaired pulmonary vascular development in bronchopulmonary dysplasia. Neonatology 107, 344–351 (2015).

    Article  PubMed  Google Scholar 

  24. Surate Solaligue, D. E., Rodríguez-Castillo, J. A., Ahlbrecht, K. & Morty, R. E. Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell Mol. Physiol. 313, L1101–l1153 (2017).

    Article  PubMed  Google Scholar 

  25. Elgendy, M. M. et al. Trends and racial disparities for acute kidney injury in premature infants: the Us national database. Pediatr. Nephrol. 36, 2789–2795 (2021).

    Article  PubMed  Google Scholar 

  26. Bignall, O. N. R., Harer, M. W., Sanderson, K. R. & Starr, M. C. Commentary on “trends and racial disparities for acute kidney injury in premature infants: the US national database”. Pediatr. Nephrol. 36, 2587–2591 (2021).

    Article  PubMed  Google Scholar 

  27. D’Angio, C. T. & Maniscalco, W. M. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci. 7, d1609–d1623 (2002).

    Article  PubMed  Google Scholar 

  28. Meller, S. & Bhandari, V. Vegf levels in humans and animal models with Rds and Bpd: temporal relationships. Exp. Lung Res. 38, 192–203 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Been, J. V. et al. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr. Res. 67, 83–89 (2010).

    Article  CAS  PubMed  Google Scholar 

  30. Balena-Borneman, J. et al. Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants. Pediatr. Res. 81, 519–525 (2017).

    Article  CAS  PubMed  Google Scholar 

  31. Hu, R., Cheng, Y., Jing, H. & Wu, H. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via Pi3k/Akt pathway. Shock 42, 327–336 (2014).

    Article  CAS  PubMed  Google Scholar 

  32. Vrijlandt, E. J., Gerritsen, J., Boezen, H. M., Grevink, R. G. & Duiverman, E. J. Lung function and exercise capacity in young adults born prematurely. Am. J. Respir. Crit. Care Med. 173, 890–896 (2006).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Samantha Wallace (Department of Pediatrics, Indiana University School of Medicine) for help with technical editing and proofreading of this manuscript. We would like to thank Lynn Dill, RN, and Emily Pao for their assistance in coordinating the REPaIReD study. We would like to thank the investigators, clinicians, research personnel, study teams, and families who participated in the PENUT Trial. This study was supported by grants R01DK103608, U01NS077955, and U01NS077953. Funding sources for this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author information

Author notes

  1. These authors contributed equally: Sangeeta Hingorani7, David J. Askenazi.

  2. A full list of members and their affiliations appears in the Supplementary Information.

Authors and Affiliations

  1. Division of Pediatric Nephrology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA

    Michelle C. Starr

  2. Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, IN, USA

    Michelle C. Starr

  3. Department of Biostatistics, University of Washington, Seattle, WA, USA

    Robert H. Schmicker & Patrick Heagerty

  4. Division of Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA

    Brian A. Halloran & David J. Askenazi

  5. University of Rochester and Golisano Children’s Hospital, Rochester, NY, USA

    Patrick Brophy

  6. Pediatric Nephrology & Hypertension, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Stuart L. Goldstein

  7. Department of Pediatrics, Seattle Children’s Hospital and University of Washington, Seattle, WA, USA

    Sandra E. Juul & Sangeeta Hingorani

Authors
  1. Michelle C. Starr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert H. Schmicker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian A. Halloran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick Heagerty
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrick Brophy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stuart L. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sandra E. Juul
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sangeeta Hingorani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David J. Askenazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the PENUT Trial Consortium

Contributions

Dr. Starr conceptualized and designed this study, assisted with biomarker performance and data analysis, drafted the initial manuscript, and reviewed and revised the manuscript. Mr. Schmicker and Halloran performed biomarker and data analysis and critically revised the manuscript. Drs. Heagerty, Brophy, Goldstein, and Juul made substantial contributions to the conception of this project and reviewed and revised the manuscript. Drs. Hingorani and Askenazi provided oversight and made substantial contributions to the design of this study and acquisition of data, reviewed, and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Michelle C. Starr.

Ethics declarations

Competing interests

All authors report no real or perceived conflicts of interest that could affect the study design; collection, analysis and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other commitments and funding sources that are not directly related to this study. R.H.S. receives grant funding for studies not related to this project from NHLBI and PCORI. S.L.G. reports personal fees from and a position as a consultant to Nuwellis, Renibus, ExThera, Reata and Medtronic Inc. S.L.G. has an equity interest in MediBeacon, Inc. S.L.G. receives grant funding from and serves as a consultant and on a Speaker’s Bureau for Baxter Healthcare, Inc. S.L.G. receives grant funding and serves as a consultant for BioPorto Diagnostics, Inc. S.L.G. serves on a Speaker’s Bureau for Fresenius Medical Corporation. D.J.A. consults for Baxter, Nuwellis, Medtronic, Bioporto and Seastar Medical. He also receives grant funding for studies not related to this project from Baxter, Nuwellis, Medtronic, SeaStar Medical, Bioporto, and National Institutes of Health (R01 FD005092, U34 KD117128). He is founder and Chief Scientific Officer for Zorro-Flow Inc. He has patents pending for urine collection device and System for Continuous Renal Replacement System.

Consent to participate

Caregiver consent was required for participation in primary (PENUT) study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Starr, M.C., Schmicker, R.H., Halloran, B.A. et al. Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates. Pediatr Res (2023). https://doi.org/10.1038/s41390-023-02514-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-023-02514-4

This article is cited by

Search

Advanced search

Quick links